President Trump has signed an executive order on prescription drug prices that walks back the "pill penalty" decried by PhRMA in President Biden's Inflation Reduction Act.

The proposed rule removes measures for health equity, vaccines for healthcare staff and the social drivers of health.

The decision was the latest chapter in ongoing litigation between Humana and CMS over the validity of its star ratings. Jeff Lagasse, Editor Healthcare lease accounting insights: How two organizations ...

Tennessee-based health system Ascension Saint Thomas is entering into a joint venture with PathPoint Health, a metabolic care provider, to help individuals prevent and manage metabolic conditions, ...